Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval CNBCLilly’s Obesity Pill Foundayo…
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio Eli LillyEli Lilly…
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand CNBCLilly reports third-quarter 2026 financial…
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s CNBCExperimental…
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBCLilly's EloraTZP (combination of eloralintide…
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s CNBCNovo Nordisk (NVO) Sets…
Lilly Wachowski on Her New Studio Anarchists United, the Black Power Origins of ‘The Matrix’ and How ‘Harry…
